Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Intestinal microbiota and diabetic kidney diseases: the Role of microbiota and derived metabolites inmodulation of renal inflammation and disease progression
Charlotte M. Mosterd, Mehmet Kanbay, Bert‐Jan H. van den Born, et al.
Best Practice & Research Clinical Endocrinology & Metabolism (2021) Vol. 35, Iss. 3, pp. 101484-101484
Open Access | Times Cited: 62

Showing 1-25 of 62 citing articles:

Molecular mechanisms and therapeutic targets for diabetic kidney disease
Katherine R. Tuttle, Rajiv Agarwal, Charles E. Alpers, et al.
Kidney International (2022) Vol. 102, Iss. 2, pp. 248-260
Open Access | Times Cited: 294
Systemic immune-inflammation index is associated with diabetic kidney disease in Type 2 diabetes mellitus patients: Evidence from NHANES 2011-2018
Wencong Guo, Yancheng Song, Yan Sun, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 188
Perturbed gut microbiome and fecal and serum metabolomes are associated with chronic kidney disease severity
Haichao Wang, Aisima Ainiwaer, Yaxiang Song, et al.
Microbiome (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 56
Tryptophan Metabolism and Gut Microbiota: A Novel Regulatory Axis Integrating the Microbiome, Immunity, and Cancer
Yingjian Hou, Jing Li, Shuhuan Ying
Metabolites (2023) Vol. 13, Iss. 11, pp. 1166-1166
Open Access | Times Cited: 44
Moutan Cortex polysaccharide ameliorates diabetic kidney disease via modulating gut microbiota dynamically in rats
Meng Zhang, Licheng Yang, Maomao Zhu, et al.
International Journal of Biological Macromolecules (2022) Vol. 206, pp. 849-860
Closed Access | Times Cited: 57
Empagliflozin ameliorates type 2 diabetes mellitus-related diabetic nephropathy via altering the gut microbiota
Le Deng, Yang Yang, Gaosi Xu
Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids (2022) Vol. 1867, Iss. 12, pp. 159234-159234
Closed Access | Times Cited: 42
Metabolomic Markers of Ultra-Processed Food and Incident CKD
Donghan Su, Jingsha Chen, Shutong Du, et al.
Clinical Journal of the American Society of Nephrology (2023) Vol. 18, Iss. 3, pp. 327-336
Open Access | Times Cited: 25
Association Between Trimethylamine N-oxide and Adverse Kidney Outcomes and Overall Mortality in Type 2 Diabetes Mellitus
Ping-Shaou Yu, Ping‐Hsun Wu, Wei‐Wen Hung, et al.
The Journal of Clinical Endocrinology & Metabolism (2024) Vol. 109, Iss. 8, pp. 2097-2105
Open Access | Times Cited: 9
A Link between Chronic Kidney Disease and Gut Microbiota in Immunological and Nutritional Aspects
Paulina Mertowska, Sebastian Mertowski, Julia Wojnicka, et al.
Nutrients (2021) Vol. 13, Iss. 10, pp. 3637-3637
Open Access | Times Cited: 45
The Profile and Function of Gut Microbiota in Diabetic Nephropathy
Weihong Chen, Mengjiu Zhang, Yan Guo, et al.
Diabetes Metabolic Syndrome and Obesity (2021) Vol. Volume 14, pp. 4283-4296
Open Access | Times Cited: 44
Faecal Microbiota Transplantation and Chronic Kidney Disease
Ji Bian, Ann Liebert, Brian Bicknell, et al.
Nutrients (2022) Vol. 14, Iss. 12, pp. 2528-2528
Open Access | Times Cited: 34
Microbial Tryptophan Metabolism Tunes Host Immunity, Metabolism, and Extraintestinal Disorders
Moyan Liu, Max Nieuwdorp, Willem M. de Vos, et al.
Metabolites (2022) Vol. 12, Iss. 9, pp. 834-834
Open Access | Times Cited: 32
Gut Microbiota and Aging: Traditional Chinese Medicine and Modern Medicine
Jinfan Li, Dong Li, Yajie Chen, et al.
Clinical Interventions in Aging (2023) Vol. Volume 18, pp. 963-986
Open Access | Times Cited: 18
Traditional Chinese medicine improved diabetic kidney disease through targeting gut microbiota
Xiaqing Wu, Lei Zhao, Yanlong Zhao, et al.
Pharmaceutical Biology (2024) Vol. 62, Iss. 1, pp. 423-435
Open Access | Times Cited: 6
Molecular mechanisms of gut microbiota in diabetic nephropathy
Gang Cheng, Yulin Liu, Rong Guo, et al.
Diabetes Research and Clinical Practice (2024) Vol. 213, pp. 111726-111726
Closed Access | Times Cited: 6
Enterorenal crosstalks in diabetic nephropathy and novel therapeutics targeting the gut microbiota
Yinhua Ni, Liujie Zheng, Sujie Nan, et al.
Acta Biochimica et Biophysica Sinica (2022) Vol. 54, Iss. 10, pp. 1406-1420
Open Access | Times Cited: 27
Efficacy and safety of Zicuiyin decoction on diabetic kidney disease: A multicenter, randomized controlled trial
Jia Liu, Lidong Gao, Bin Fu, et al.
Phytomedicine (2022) Vol. 100, pp. 154079-154079
Closed Access | Times Cited: 25
The role and mechanism of the gut microbiota in the development and treatment of diabetic kidney disease
Xiaofang Wu, Lei Zhao, Yújiāng Zhāng, et al.
Frontiers in Physiology (2023) Vol. 14
Open Access | Times Cited: 15
Intestinal microbiome diversity of diabetic and non-diabetic kidney disease: Current status and future perspective
Soumik Das, Gnanasambandan Ramanathan
Life Sciences (2023) Vol. 316, pp. 121414-121414
Closed Access | Times Cited: 13
The influence and therapeutic effect of microbiota in systemic lupus erythematosus
Chuzi Mo, Jiaming Bi, Siwei Li, et al.
Microbiological Research (2024) Vol. 281, pp. 127613-127613
Closed Access | Times Cited: 5
Investigating the Effects of Metabolic and Bariatric Surgery on Systemic Immune‐Inflammation Index and Its Relationship With Smoking
Hatice Toprak, Şükrü Salih Toprak
World Journal of Surgery (2025)
Open Access
The Role and Mechanism of Gut Microbiota in the Development of Diabetic Nephropathy
梅 韩
Advances in Clinical Medicine (2025) Vol. 15, Iss. 02, pp. 215-222
Closed Access
Associations Between Gut Microbiota and Diabetic Nephropathy: A Mendelian Randomization Study
Yujun Xiong, Xingyun Zhu, Hua-Zhao Xu, et al.
Aging Medicine (2025) Vol. 8, Iss. 1
Open Access
Beneficial Effects of Butyrate on Kidney Disease
Tram N. Diep, Haoxin Liu, Liang‐Jun Yan
Nutrients (2025) Vol. 17, Iss. 5, pp. 772-772
Open Access
Punicalagin alleviates renal injury via the gut-kidney axis in high-fat diet-induced diabetic mice
Qinglian Hua, Yaling Han, Haifeng Zhao, et al.
Food & Function (2021) Vol. 13, Iss. 2, pp. 867-879
Closed Access | Times Cited: 31
Page 1 - Next Page

Scroll to top